821P - Kinetics of prostate-specific antigen (PSA) as a marker of abiraterone acetate (AA) efficacy in patients (p) with metastatic castrate-resistant prostate cancer (mCRPC)

Autor: España Fernandez, S., Piulats, J.M., Sala, N., Velarde, J.M., Ferrandiz, U., Etxaniz Ulazia, O., Heras Lopez, L., Barretina Ginesta, M.P., Garcia del Muro, X., Font, A.
Zdroj: In Annals of Oncology October 2018 29 Supplement 8
Databáze: ScienceDirect